Drug reference directory
Drug reference

ospemifene

Selective Estrogen Receptor Modulator (SERM) · Gynecological Agent

Selective Estrogen Receptor Modulator (SERM)Gynecological Agent
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
6 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 6 →
  • CarfilzomibSevereDatabaseDDInter
  • FluconazoleSevereDatabaseDDInter
  • LenalidomideSevereDatabaseDDInter
  • PomalidomideSevereDatabaseDDInter

Mechanism

Not yet extracted

Indications

vulvovaginal atrophydyspareunia

Side effects

Serious
  • increased risk of thromboembolism
  • potential thickening of endometrium

Drug interactions

Carfilzomib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Fluconazole
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Lenalidomide
Severe
Database

Clinical effect not specified

Source: DDInter

Pomalidomide
Severe
Database

Clinical effect not specified

Source: DDInter

Thalidomide
Severe
Database

Clinical effect not specified

Source: DDInter

Tranexamic Acid
Severe
Database

Clinical effect not specified

Source: DDInter

6 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.

Related guidelines

Other Selective Estrogen Receptor Modulator (SERM) drugs

Ask House about ospemifene

Continue into a citation-backed clinical answer with the drug context already attached.

Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10